Latest papers

Biodegradable microfibers deliver the antitumor drug temozolomide to glioma C6 cells in vitro.

[Understanding clinical neuropsychology: a basic approach (6) brain tumor].

Imaging and response criteria in gliomas.

Efficacy and safety/toxicity study of recombinant vaccinia virus JX-594 in two immunocompetent animal models of glioma.

Pifithrin-α as a potential cytoprotective agent in radiotherapy: protection of normal tissue without decreasing therapeutic efficacy in glioma cells.

[11C-methionine positron emission tomography in nontumorous brain lesions].

T-cell immunotherapy for malignant glioma: toward a combined approach.

Functional microRNA is transferred between glioma cells.

Novel magnetic/ultrasound focusing system enhances nanoparticle drug delivery for glioma treatment.

Early presentation of de novo high grade glioma with epileptic seizures: electroclinical and neuroimaging findings.

Short hairpin RNA-mediated fibronectin knockdown delays tumor growth in a mouse glioma model.

[Glioma treatment strategies using mesenchymal stem cells].

MAb 806 enhances the efficacy of ionizing radiation in glioma xenografts expressing the de2-7 epidermal growth factor receptor.

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma.

Click-xylosides mitigate glioma cell invasion in vitro.

MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.

Glioma proteomics: Status and perspectives

Maturation of tumor vasculature by interferon-beta disrupts the vascular niche of glioma stem cells.

Effect of inhibition of the ROCK isoform on RT2 malignant glioma cells.

Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.